Parathyroid carcinoma: A 16-year experience in a single institution

Endocrine Journal

Volumn 57, Issue 6, 2010, Pages 493-497

  Lee, Yong Sang ^a   Hong, Soon Won ^a   Jeong, Jong Ju ^a   Nam, Kee Hyun ^a   Chung, Woong Youn ^a   Chang, Hang Seok ^a   Park, Cheong Soo ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Hypercalcemia; Parathyroid carcinoma; Parathyroid hormone; Primary hyperparathyroidism; Radical resection

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE; CALCIUM;

ADULT; ARTICLE; BONE PAIN; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG METASTASIS; MALE; PARATHYROID CARCINOMA; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; TREATMENT OUTCOME; BLOOD; DIAGNOSTIC USE; MIDDLE AGED; PARATHYROID NEOPLASMS;

ADULT; CALCIUM; FEMALE; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77954753268     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K09E-365     Document Type: Article

References (24)

1. Wang CA, Gaz RD (1985) Natural history of parathyroidcarcinoma. Diagnosis, treatment, and results. Am JSurg 149:522-527.
2. de Quevain F (1904) Parastruma maligna aberrata. Deutsche Zeitschr Chirurgie 100:334-352.
3. Sainton P, Millot JL (1933) Dégénérence maligne d́unadénome parathyroidien éosinophile au cours d'unemaladie de Recklinghausen. Ann Anat Pathol 10:813-818.
4. Schantz A, Castleman B (1973) Parathyroid carcinoma:A study of 70 cases. Cancer 31:600-605.
5. Rubello D, Casara D, Dwamena BA, Shapiro B (2001) Parathyroid carcinoma. A concise review. MinervaEndocrinol 26:59-64.
6. Holmes EC, Morton DL, Ketcham AS (1969) Parathyroid carcinoma: a collective review. Ann Surg 169:631-640.
7. Kay S, Hume DM (1973) Carcinoma of the parathyroidgland. How reliable are the clinical and histologicfeatures? Arch Pathol 96:316-319.
8. Ireland JP, Fleming SJ, Levison DA, Cattell WR, Baker LR (1985) Parathyroid carcinoma associated withchronic renal failure and previous radiotherapy to theneck. J Clin Pathol 38:1114-1118.
9. Miki H, Sumitomo M, Inoue H, Kita S, Monden Y (1996) Parathyroid carcinoma in patients with chronicrenal failure on maintenance hemodialysis. Surgery 120:897-901.
10. Wassif WS, Moniz CF, Friedman E, Wong S, Weber G, Nordenskjöld M, Peters TJ, Larsson C (1993) Familialisolated hyperparathyroidism: a distinct genetic entitywith an increased risk of parathyroid cancer. J ClinEndocrinol Metab 77:1485-1489.
11. Marx SJ, Simonds WF, Agarwal SK, Burns AL, Weinstein LS, Cochran C, Skarulis MC, Spiegel AM, Libutti SK, Alexander HR Jr, Chen CC, Chang R, Chandrasekharappa SC, Collins FS (2002) Hyperparathyroidism in hereditary syndromes: specialexpressions and special managements. J Bone MinerRes 17:N37-N43.
12. Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, Simonds WF, Gillanders EM, Kennedy AM, Chen JD, Agarwal SK, Sood R, Jones MP, Moses TY, Haven C, Petillo D, Leotlela PD, Harding B, Cameron D, Pannett AA, Höög A, Heath H 3rd, James-Newton LA, Robinson B, Zarbo RJ, Cavaco BM, Wassif W, Perrier ND, Rosen IB, Kristoffersson U, Turnpenny PD, Farnebo LO, Besser GM, Jackson CE, Morreau H, Trent JM, Thakker RV, Marx SJ, Teh BT, Larsson C, Hobbs MR (2002) HRPT2, encoding parafibromin, is mutated inhyperparathyroidism-jaw tumor syndrome. Nat Genet 32:676-680.
13. Weinstein LS, Simonds WF (2003) HRPT2, a markerof parathyroid cancer. N Engl J Med 349:1691-1692.
14. Howell VM, Haven CJ, Kahnoski K, Khoo SK, Petillo D, Chen J, Fleuren GJ, Robinson BG, Delbridge LW, Philips J, Nelson AE, Krause U, Hammje K, Dralle H, Hoang-Vu C, Gimm O, Marsh DJ, Morreau H, Teh BT (2003) HRPT2 mutations are associated with malignancyin sporadic parathyroid tumours. J Med Genet 40:657-663.
15. Koea JB, Shaw JH (1999) Parathyroid cancer: biologyand management. Surg Oncol 8:155-165.
16. Wynne AG, van Heerden J, Carney JA, Fitzpatrick LA (1992) Parathyroid carcinoma: clinical and pathologicfeatures in 43 patients. Medicine (Baltimore) 71:197-205.
17. Silverberg SJ, Shane E, de la Cruz L, Dempster DW, Feldman F, Seldin D, Jacobs TP, Siris ES, Cafferty M, Parisien MV, Lindsay R, Clemens TL, Bilezikian JP (1989) Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 4:283-291.
18. Hundahl SA, Fleming ID, Fremgen AM, Menck HR (1999) Two hundred eighty-six cases of parathyroidcarcinoma treated in the U.S. between 1985-1995:a National Cancer Data Base Report. The AmericanCollege of Surgeons Commission on Cancer and theAmerican Cancer Society. Cancer 86:538-544.
19. Slatopolsky E, Finch J, Clay P, Martin D, Sicard G, Singer G, Gao P, Cantor T, Dusso A (2000) A novelmechanism for skeletal resistance in uremia. Kidney Int 58:753-761.
20. Thompson SD, Prichard AJ (2004) The management ofparathyroid carcinoma. Curr Opin Otolaryngol HeadNeck Surg 12:93-97.
21. Spinelli C, Bonadio AG, Berti P, Materazzi G, Miccoli P (2000) Cutaneous spreading of parathyroid carcinomaafter ine needle aspiration cytology. J EndoscinolInvest 23:255-257.
22. Shane E (2001) Clinical review 122: Parathyroid carcinoma. J Clin Endocrinol Metab 86:485-493.
23. Busaidy NL, Jimenez C, Habra MA, Schultz PN, El-Naggar AK, Clayman GL, Asper JA, Diaz EM Jr, Evans DB, Gagel RF, Garden A, Hoff AO, Lee JE, Morrison WH, Rosenthal DI, Sherman SI, Sturgis EM, Waguespack SG, Weber RS, Wirfel K, Vassilopoulou-Sellin R (2004) Parathyroid carcinoma: a 22-yearexperience. Head Neck 26:716-726.
24. Rodgers SE, Perrier ND (2006) Parathyroid carcinoma. Curr Opin Oncol 18:16-22.